Neovacs S.A. (EPA:ALNEV)
France
· Delayed Price · Currency is EUR 0.0276
+0.0142 (105.97%)
Apr 29, 2025, 9:45 AM CET
Neovacs Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 0.68 | 0.53 | 0 | 0.02 | 0.03 | - | Upgrade
|
| Other Revenue | 0.14 | - | - | - | - | 0.1 | Upgrade
|
| Revenue | 0.82 | 0.53 | 0 | 0.02 | 0.03 | 0.1 | Upgrade
|
| Revenue Growth (YoY) | 1439.62% | 47868.71% | -95.07% | -24.32% | -68.70% | 1259.34% | Upgrade
|
| Cost of Revenue | 3.57 | 4 | 3.4 | 4.56 | 1.72 | 5.39 | Upgrade
|
| Gross Profit | -2.74 | -3.47 | -3.4 | -4.54 | -1.69 | -5.3 | Upgrade
|
| Selling, General & Admin | 3.19 | 3.12 | 2.71 | 2.96 | 1.65 | 2.82 | Upgrade
|
| Other Operating Expenses | 0.68 | 0.15 | 0.18 | 0.23 | 0.1 | -0 | Upgrade
|
| Operating Expenses | 4.05 | 3.44 | 3.04 | 3.29 | 1.8 | 2.88 | Upgrade
|
| Operating Income | -6.79 | -6.91 | -6.44 | -7.83 | -3.49 | -8.17 | Upgrade
|
| Interest Expense | - | - | - | -0 | -0 | -0.11 | Upgrade
|
| Interest & Investment Income | 4.48 | 4.19 | 4.22 | 0.19 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.14 | -0.14 | -0.07 | 0 | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -11.08 | -6.08 | -0.9 | -2.06 | -2.13 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -13.54 | -8.94 | -3.19 | -9.7 | -5.61 | -8.28 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.33 | -0.33 | -0.08 | -0.18 | - | -0.16 | Upgrade
|
| Asset Writedown | -21.03 | - | - | -0 | - | - | Upgrade
|
| Other Unusual Items | -0.39 | -0.35 | -1.08 | -2.6 | -1.07 | -0.86 | Upgrade
|
| Pretax Income | -36.48 | -9.62 | -4.35 | -12.48 | -6.68 | -9.3 | Upgrade
|
| Income Tax Expense | -1.03 | -0.88 | -0.8 | -0.64 | -0.54 | -1.75 | Upgrade
|
| Net Income | -35.45 | -8.74 | -3.55 | -11.84 | -6.14 | -7.55 | Upgrade
|
| Net Income to Common | -35.45 | -8.74 | -3.55 | -11.84 | -6.14 | -7.55 | Upgrade
|
| Shares Outstanding (Basic) | - | - | - | - | 674 | 158 | Upgrade
|
| Shares Outstanding (Diluted) | - | - | - | - | 674 | 158 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 327.36% | 46.24% | Upgrade
|
| EPS (Basic) | - | - | - | - | -0.01 | -0.05 | Upgrade
|
| EPS (Diluted) | - | - | - | - | -0.01 | -0.05 | Upgrade
|
| Free Cash Flow | -1.68 | -2.12 | -4.6 | -10.26 | -5.86 | -8.1 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | - | -0.01 | -0.05 | Upgrade
|
| Operating Margin | -825.06% | -1294.97% | -579583.27% | -34725.65% | -11723.46% | -8590.86% | Upgrade
|
| Profit Margin | -4305.31% | -1639.15% | -319109.98% | -52512.21% | -20624.03% | -7932.63% | Upgrade
|
| Free Cash Flow Margin | -204.58% | -396.80% | -413782.37% | -45498.69% | -19665.26% | -8514.47% | Upgrade
|
| EBITDA | -5.93 | -6.06 | -6.29 | -7.73 | -3.44 | -8.12 | Upgrade
|
| D&A For EBITDA | 0.87 | 0.85 | 0.15 | 0.1 | 0.06 | 0.06 | Upgrade
|
| EBIT | -6.79 | -6.91 | -6.44 | -7.83 | -3.49 | -8.17 | Upgrade
|
| Revenue as Reported | 0.9 | 0.54 | 0.01 | - | 0.03 | 0.28 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.